Cowen and Company’s Encompass Health EHC Stock Holding History

Cowen and Company’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,302	Closed	-$137K	–	679
2021 Q3	$137K	Buy	+2,302	New	+$145K	0.01%	288

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cowen and Company's EHC Position: Q4 2021 in Review

Cowen and Company sold out of Encompass Health (EHC) in Q4 2021, closing a stake of 2,302 shares — an estimated $137K sold.

Cowen and Company first reported a position in EHC in Q3 2021 and held it in 1 quarter. The position peaked at $137K in Q3 2021. 409 funds tracked by Wall St. Rank hold EHC as of Q4 2021.

Cowen and Company reported no remaining Encompass Health position as of Q4 2021 after selling out during the quarter.
Cowen and Company sold 2,302 Encompass Health shares in Q4 2021, an estimated $137K.
Cowen and Company first reported a position in Encompass Health in Q3 2021 and held it in 1 quarter.
Cowen and Company's Encompass Health position peaked at $137K in Q3 2021.
409 funds tracked by Wall St. Rank held Encompass Health as of Q4 2021.

Based on Cowen and Company's 13F filing for Q4 2021, filed 14 Feb 2022.